Skip to main content
NCBI home page
Cell Death & Disease logoLink to Cell Death & Disease
. 2020 Oct 23;11(10):905. doi: 10.1038/s41419-020-02933-9

Correction: ELABELA attenuates deoxycorticosterone acetate/salt-induced hypertension and renal injury by inhibition of NADPH oxidase/ROS/NLRP3 inflammasome pathway

Zhida Chen 1,2, Chunying Wu 1, Yuting Liu 1, Haonan Li 3, Yeyan Zhu 1, Cailing Huang 1, Huangbo Lin 1, Qiao Qiao 3, Mengming Huang 3, Qing Zhu 3,✉, Lei Wang 1,✉
PMCID: PMC7584569  PMID: 33097689

Correction to: Cell Death & Disease

10.1038/s41419-020-02912-0 published online 22 August 2020

The original version of this Article contained errors in the author affiliations.

Zhida Chen was incorrectly associated with Guangdong Metabolic Disease Research Center of Integrated Chinese and Western Medicine, Guangdong Pharmaceutical University, Guangzhou, China. Haonan Li, Qiao Qiao and Qing Zhu were incorrectly associated with Department of Nephrology, The Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China.

This has now been corrected in both the PDF and HTML versions of the Article.

Footnotes

Edited by F. Pentimalli

The original article can be found online at 10.1038/s41419-020-02912-0.

Contributor Information

Qing Zhu, Email: zyq973@hotmail.com.

Lei Wang, Email: wanglei_voice@yahoo.com.

Articles from Cell Death & Disease are provided here courtesy of Nature Publishing Group

RESOURCES